Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study will evaluate a method to detect tumor cells that are circulating in the blood without getting a biopsy. The investigators already know from other studies that cancer tumors shed a small number of cells into the bloodstream every day. These are called circulating tumor cells (CTCs). Some early studies indicate the amount and type of CTCs in the blood can help determine the status of the tumor itself and the way it is responding to treatment. In this study, the investigators will compare the number of CTCs in the blood at different time frames before and after surgery to remove the prostate.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:

• Male

• 18 years of age or older

• Pathologically confirmed diagnosis of prostate adenocarcinoma

• Non-metastatic prostate cancer

• Planned radical prostatectomy at Massachusetts General Hospital

Locations
United States
Massachusetts
Massachsuetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Richard J Lee, MD, PhD
617-724-4000
Time Frame
Start Date: 2010-04
Estimated Completion Date: 2025-12
Participants
Target number of participants: 200
Treatments
Prostatectomy
Subjects with prostate cancer diagnosed on prostate biopsy who undergo radical prostatectomy at Massachusetts General Hospital
Related Therapeutic Areas
Sponsors
Collaborators: Prostate Cancer Foundation Clinical Research Consortium
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov